Deep South Musculoskeletal CERTS (DSMC)

Michael Miller RPh, DrPH

OUHSC PI (Subcontractor)

Agency: Univ. of Alabama at Birmingham (DSMC)


The proposed project, The Alabama NSAID Patient Safety Study, Phase II, Reducing Disparities in Risk Awareness and Communication, seeks to improve patient risk communication for patients taking nonsteroidal anti-inflammatory drugs (NSAIDs) and advance optimal medication use and management in particularly vulnerable populations. The project expands the role of Dr. Michael Miller with the Deep South Musculoskeletal (DSM) Center for Education and Research in Therapeutics (CERTs), which has already produced significant scholarly output through our ongoing collaboration.
     Having participated in the NSAIDs Patient Safety Study, Phase I, for nearly three years, Dr. Miller's experience and efforts from that project will inform the design and revision of data collection processes and forms for Phase II. His efforts will also provide analytical expertise, manuscript preparation, and resulting dissemination efforts.